⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NKTR News
Nektar Therapeutics
NKTR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Nektar Therapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
NKTR
NKTR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Nektar Therapeutics Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
NKTR
Pomerantz LLP Announces Class Action Lawsuit Filing Against Nektar Therapeutics, Inc. – NKTR
accessnewswire.com
NKTR
Pomerantz LLP Announces Class Action Lawsuit Against Nektar Therapeutics, Inc. – NKTR
accessnewswire.com
NKTR
Pomerantz LLP Announces Class Action Lawsuit Against Nektar Therapeutics, Inc. – NKTR
accessnewswire.com
NKTR
NKTR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
NKTR
Pomerantz LLP Announces Class Action Filing Against Nektar Therapeutics, Inc. – NKTR
accessnewswire.com
NKTR
Pomerantz LLP Announces Class Action Filing Against Nektar Therapeutics, Inc. – NKTR
accessnewswire.com
NKTR
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
prnewswire.com
NKTR
NKTR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026
globenewswire.com
NKTR